Versant Capital Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.9K Hold
1,708
﹤0.01% 1825
2026
Q1
$12.7K Hold
1,708
﹤0.01% 2034
2025
Q4
$20.1K Hold
1,708
﹤0.01% 1635
2025
Q3
$13.2K Buy
1,708
+1,009
+144% +$7.07K ﹤0.01% 1807
2025
Q2
$5.11K Sell
699
-1,607
-70% -$13K ﹤0.01% 2142
2025
Q1
$21.9K Buy
2,306
+511
+28% +$6.38K ﹤0.01% 1297
2024
Q4
$29.6K Buy
1,795
+1,142
+175% +$17.7K 0.01% 809
2024
Q3
$9.63K Hold
653
﹤0.01% 1068
2024
Q2
$9.06K Sell
653
-432
-40% -$6.13K ﹤0.01% 1023
2024
Q1
$17.1K Sell
1,085
-62
-5% -$957 ﹤0.01% 568
2023
Q4
$18.6K Buy
1,147
+551
+92% +$9.02K 0.01% 525
2023
Q3
$7.33K Sell
596
-460
-44% -$6.84K ﹤0.01% 835
2023
Q2
$17K Sell
1,056
-674
-39% -$11.1K 0.01% 568
2023
Q1
$30.1K Buy
1,730
+1,166
+207% +$16.6K 0.01% 372
2022
Q4
$5.21K Sell
564
-187
-25% -$1.74K ﹤0.01% 880
2022
Q3
$6K Buy
751
+120
+19% +$1.19K ﹤0.01% 791
2022
Q2
$5K Buy
631
+271
+75% +$2.59K ﹤0.01% 867
2022
Q1
$4K Buy
+360
New +$7.58K ﹤0.01% 963

Other funds holding NEO